Cape Regional Medical Center, INC

Cape Regional Medical Center, INC was paid $39.60M by Medicaid between Jan 2018 and Dec 2024, across 275 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.

33Billing provider infoCAPE REGIONAL MEDICAL CENTER, INC
CAPE MAY COURT HOUSE, NJ 08210

33aNPI1053382697assigned 01/31/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$39.60M

24GClaims1,170,828

24DCodes billed275

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#40 of 93

Median peer was paid$30.60M

This provider vs. median1.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	151,648	$7.25M
2019	146,463	$7.04M
2020	149,635	$5.11M
2021	182,131	$5.64M
2022	207,890	$5.60M
2023	189,393	$5.14M
2024incomplete	143,668	$3.82M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	26%	35,999	33,326	$10.31M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	21%	27,258	24,662	$8.30M
G0378	Hospital observation service, per hour	7.3%	5,285	3,809	$2.87M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.8%	8,736	7,890	$1.90M
99282	Emergency department visit for the evaluation and management, low to moderate severity	3.4%	8,722	8,218	$1.35M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	2.8%	2,398	2,303	$1.12M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	2.8%	3,161	3,015	$1.09M
70450	Computed tomography, head or brain; without contrast material	1.5%	7,125	6,505	$578K
99281	Emergency department visit for the evaluation and management, self-limited or minor	1.4%	5,489	4,914	$567K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.3%	16,875	4,817	$501K
99218		1.2%	1,409	915	$488K
74177	Computed tomography, abdomen and pelvis; with contrast material	1.2%	3,382	3,141	$459K

263 more codes

74176	Computed tomography, abdomen and pelvis; without contrast material	1.1%	4,931	$426K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.0%	66,922	$403K
80048	Basic metabolic panel (calcium, ionized)	<1%	62,790	$383K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	8,376	$371K
96361	Intravenous infusion, hydration; each additional hour	<1%	10,348	$354K
80053	Comprehensive metabolic panel	<1%	38,122	$346K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	709	$330K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	18,587	$273K
97597		<1%	2,350	$269K
OP279		<1%	27,201	$243K
71046	Radiologic examination, chest; 2 views	<1%	10,531	$237K
59025	Fetal non-stress test	<1%	1,412	$217K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	335	$211K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	5,282	$211K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	14,636	$206K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,082	$197K
36415	Collection of venous blood by venipuncture	<1%	68,462	$186K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,392	$162K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,294	$161K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	12,833	$139K
71045	Radiologic examination, chest; single view	<1%	8,574	$139K
93971		<1%	1,301	$128K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	6,007	$123K
96375	Therapeutic injection; each additional sequential IV push	<1%	8,755	$122K
85027		<1%	32,388	$114K
97161		<1%	2,380	$105K
76801		<1%	985	$99K
76830	Ultrasound, transvaginal	<1%	1,143	$99K
62323		<1%	176	$96K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	341	$95K
93970		<1%	532	$94K
84484		<1%	14,072	$90K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	3,633	$89K
OP252		<1%	40,337	$89K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	657	$88K
41899	Unlisted procedure, dentoalveolar structures	<1%	101	$88K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	5,421	$88K
71250		<1%	753	$87K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	7,008	$87K
83735		<1%	19,878	$77K
84443	Thyroid stimulating hormone (TSH)	<1%	13,414	$70K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,141	$69K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	3,091	$67K
93017		<1%	325	$67K
85610		<1%	22,626	$62K
OP251		<1%	27,680	$62K
80320		<1%	6,070	$57K
82550		<1%	9,639	$56K
73630		<1%	2,647	$55K
88342		<1%	2,248	$54K
80076		<1%	13,654	$54K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	818	$54K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	6,001	$52K
94060		<1%	378	$52K
82948		<1%	9,294	$50K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,794	$49K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	5,437	$48K
80061	Lipid panel	<1%	10,897	$48K
73130		<1%	2,223	$47K
95806		<1%	44	$47K
73564		<1%	1,998	$45K
87040		<1%	3,282	$44K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	1,534	$43K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	444	$42K
73610		<1%	2,159	$42K
J2704	Injection, propofol, 10 mg	<1%	4,662	$42K
83605		<1%	3,400	$41K
87086	Culture, bacterial; quantitative colony count, urine	<1%	13,111	$41K
83880		<1%	4,936	$40K
85730		<1%	10,096	$39K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	929	$38K
72110		<1%	912	$36K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,427	$34K
81001		<1%	14,414	$34K
87400		<1%	8,008	$32K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,991	$31K
73030		<1%	1,273	$31K
96376		<1%	2,238	$29K
84145		<1%	2,056	$29K
87077		<1%	6,613	$29K
83690		<1%	8,442	$28K
81003		<1%	6,288	$26K
83036	Hemoglobin; glycosylated (A1C)	<1%	11,291	$26K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	2,600	$25K
73110		<1%	1,229	$25K
81025		<1%	11,372	$24K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,587	$22K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,585	$21K
84100		<1%	5,072	$20K
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	49,988	$19K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,743	$19K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	167	$19K
87070		<1%	3,997	$17K
29515		<1%	811	$17K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	6,162	$15K
29125		<1%	722	$15K
80164		<1%	3,264	$14K
82150		<1%	3,351	$14K
OP258		<1%	21,497	$14K
84702		<1%	1,389	$12K
86885		<1%	1,921	$12K
90715		<1%	1,645	$12K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,565	$12K
86900		<1%	2,777	$11K
73502		<1%	490	$10K
82607		<1%	3,184	$10K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	4,297	$10K
82805		<1%	822	$10K
70498		<1%	86	$10K
94729		<1%	377	$10K
J2060	Injection, lorazepam, 2 mg	<1%	1,685	$10K
82140		<1%	1,463	$10K
82248		<1%	1,724	$10K
12001		<1%	309	$10K
86901		<1%	2,796	$10K
45384		<1%	45	$10K
82271		<1%	6,843	$9K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	12	$9K
36600		<1%	814	$8K
74018		<1%	347	$8K
94727		<1%	376	$8K
84153		<1%	1,285	$8K
70496		<1%	158	$8K
86403		<1%	2,611	$8K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,733	$7K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,647	$7K
94760		<1%	963	$7K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	3,110	$7K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	165	$7K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	8,166	$7K
85651		<1%	3,163	$6K
88313		<1%	439	$6K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	282	$6K
80177		<1%	1,362	$6K
85379		<1%	2,384	$6K
OP272		<1%	1,254	$6K
83874		<1%	1,203	$6K
87205		<1%	1,353	$6K
OP270		<1%	109	$6K
OP229		<1%	105	$5K
86140		<1%	2,471	$5K
96367		<1%	126	$5K
73080		<1%	216	$5K
82746		<1%	1,701	$5K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	17	$5K
82728		<1%	1,514	$5K
10060		<1%	165	$4K
70486		<1%	92	$4K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	133	$4K
84436		<1%	1,593	$4K
87088		<1%	365	$4K
84439		<1%	1,919	$4K
97166		<1%	65	$4K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,855	$3K
C1769	Guide wire	<1%	225	$3K
82553		<1%	1,210	$3K
87807		<1%	899	$3K
J1170	Injection, hydromorphone, up to 4 mg	<1%	2,324	$2K
84134		<1%	1,689	$2K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	877	$2K
76770		<1%	27	$2K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	2,022	$2K
93226		<1%	12	$2K
93880		<1%	13	$2K
73590		<1%	85	$2K
J1630	Injection, haloperidol, up to 5 mg	<1%	684	$2K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,768	$2K
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,224	$2K
71020		<1%	30	$2K
83540		<1%	1,873	$2K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	863	$2K
95819		<1%	12	$2K
93225		<1%	12	$2K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	990	$2K
83550		<1%	1,328	$2K
77003		<1%	934	$2K
86592		<1%	277	$2K
84479		<1%	694	$2K
29530		<1%	82	$2K
90686		<1%	29	$2K
97116		<1%	67	$2K
84481		<1%	545	$1K
82947		<1%	339	$1K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	12	$1K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	1,310	$1K
12002		<1%	25	$1K
72050		<1%	38	$1K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	150	$989.45
73090		<1%	52	$923.04
87428		<1%	60	$912.84
80185		<1%	132	$895.03
84703		<1%	318	$857.19
OP710		<1%	34	$825.91
88304		<1%	46	$821.41
97162		<1%	12	$786.49
71010		<1%	13	$764.27
J1644	Injection, heparin sodium, per 1000 units	<1%	216	$714.38
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	1,675	$700.08
86618		<1%	13	$674.00
87324		<1%	116	$660.39
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	13	$608.67
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,891	$603.09
74022		<1%	34	$600.34
94010		<1%	19	$556.56
90675		<1%	26	$554.29
86803		<1%	27	$540.25
99213	Doctor's office visit, returning patient (routine)	<1%	22	$525.06
J3370	Injection, vancomycin hcl, 500 mg	<1%	93	$524.36
84480		<1%	68	$497.89
OP250		<1%	685	$472.09
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	69	$463.47
82043		<1%	792	$433.94
84550		<1%	480	$404.60
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	41,837	$363.15
J3475	Injection, magnesium sulfate, per 500 mg	<1%	285	$351.08
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	13	$333.42
87340		<1%	13	$311.35
87181		<1%	130	$296.17
85045		<1%	105	$280.54
83721		<1%	166	$274.50
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	3,997	$270.15
70480		<1%	13	$258.86
73140		<1%	28	$235.23
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	15	$231.00
83615		<1%	119	$188.05
86308		<1%	136	$149.56
80162		<1%	15	$143.19
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	152	$139.30
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	24	$119.53
87186		<1%	145	$116.32
94664		<1%	57	$113.87
82272		<1%	66	$109.27
80329		<1%	27	$102.14
J1815	Injection, insulin, per 5 units	<1%	32	$93.10
85014		<1%	164	$91.70
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	<1%	172	$90.46
OP259		<1%	191	$77.23
86762		<1%	13	$76.00
85018		<1%	164	$73.10
87045		<1%	65	$62.80
86769		<1%	13	$55.29
87081		<1%	12	$53.68
82570		<1%	54	$46.89
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	91	$46.76
J0736	Injection, clindamycin phosphate, 300 mg	<1%	110	$46.66
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	124	$44.66
J8540	Dexamethasone, oral, 0.25 mg	<1%	165	$39.28
85652		<1%	81	$37.32
83970		<1%	12	$33.02
84154		<1%	25	$32.14
J7510	Prednisolone oral, per 5 mg	<1%	140	$25.80
87449		<1%	13	$24.00
S0077	Injection, clindamycin phosphate, 300 mg	<1%	104	$20.32
82040		<1%	26	$17.64
J7030	Infusion, normal saline solution , 1000 cc	<1%	116	$11.88
J1171	Injection, hydromorphone, 0.1 mg	<1%	23	$11.31
J3490	Unclassified drugs	<1%	71	$8.70
80069		<1%	43	$8.70
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	122	$8.55
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	55	$7.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	12	$1.00
OP450		0%	13	$0.00
J7120	Ringers lactate infusion, up to 1000 cc	0%	45	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGILL, MARK (VICE PRESIDENT FINANCE & CEO)

Same official

Other billing entities under GILL, MARK

Full network →

Provider	Location	Paid
Cape Cardiology Associates INC	Cape May Court House, NJ	$8K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.